From Wikipedia, the free encyclopedia
Combination drug
Finasteride/tadalafil, sold under the brand name Entadfi, is a
fixed-dose combination medication used for the treatment of
benign prostatic hyperplasia (BPH).
[1]
[2]
[3] It contains
finasteride and
tadalafil.
[1] It is taken by mouth.
[1]
It was approved for medical use in the United States in December 2021.
[1]
[4]
Medical uses
Finasteride/tadalafil is indicated to treat benign prostatic hyperplasia (BPH) in men.
[1]
References
External links
-
"Finasteride". Drug Information Portal. U.S. National Library of Medicine.
-
"Tadalafil". Drug Information Portal. U.S. National Library of Medicine.
|
---|
Androgens (incl.
AASTooltip anabolic–androgenic steroid) | |
---|
Antiandrogens |
ARTooltip Androgen receptor
antagonists | |
---|
Steroidogenesis inhibitors | |
---|
Antigonadotropins |
-
D2 receptor
antagonists (
prolactin releasers) (e.g.,
domperidone,
metoclopramide,
risperidone,
haloperidol,
chlorpromazine,
sulpiride)
-
Estrogens (e.g.,
bifluranol,
diethylstilbestrol,
estradiol,
estradiol esters,
ethinylestradiol,
ethinylestradiol sulfonate,
paroxypropione)
-
GnRH agonists (e.g.,
leuprorelin)
-
GnRH antagonists (e.g.,
cetrorelix)
-
Progestogens (incl.,
chlormadinone acetate,
cyproterone acetate,
hydroxyprogesterone caproate,
gestonorone caproate,
medroxyprogesterone acetate,
megestrol acetate)
|
---|
Others | |
---|
|
---|
|